Review for "Double‐blind, randomized, placebo‐controlled crossover trial to evaluate the clinical efficacy of rifaximin in patients with moderate to severe active Crohn’s disease"

Mapping Intimacies ◽

10.1002/ygh2.416/v1/review1 ◽

2020 ◽

Author(s):

Raymond Cross

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Clinical Efficacy ◽

Crossover Trial ◽

Download Full-text

Double‐blind, randomised, placebo‐controlled crossover trial to evaluate the clinical efficacy of rifaximin in patients with moderate to severe active Crohn’s disease

GastroHep ◽

10.1002/ygh2.416 ◽

2020 ◽

Vol 2 (5) ◽

pp. 185-192 ◽

Author(s):

Scott D. Lee ◽

Anand Singla ◽

Stephen J. Rulyak ◽

Kindra Clark‐Snustad

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Clinical Efficacy ◽

Crossover Trial ◽

Download Full-text

Decision letter for "Double‐blind, randomized, placebo‐controlled crossover trial to evaluate the clinical efficacy of rifaximin in patients with moderate to severe active Crohn’s disease"

10.1002/ygh2.416/v1/decision1 ◽

2020 ◽

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Clinical Efficacy ◽

Crossover Trial ◽

Download Full-text

Author response for "Double‐blind, randomized, placebo‐controlled crossover trial to evaluate the clinical efficacy of rifaximin in patients with moderate to severe active Crohn’s disease"

10.1002/ygh2.416/v2/response1 ◽

2020 ◽

Author(s):

Scott D Lee ◽

Anand Singla ◽

Stephen J Rulyak ◽

Kindra Clark‐Snustad

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Clinical Efficacy ◽

Crossover Trial ◽

Author Response ◽

Download Full-text

Decision letter for "Double‐blind, randomized, placebo‐controlled crossover trial to evaluate the clinical efficacy of rifaximin in patients with moderate to severe active Crohn’s disease"

10.1002/ygh2.416/v2/decision1 ◽

2020 ◽

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Clinical Efficacy ◽

Crossover Trial ◽

Download Full-text

Sa1771 - Double-Blind, Randomized, Placebo-Controlled, Crossover Trial to Evaluate Induction of Clinical Response in Patients with Moderate-Severe Crohn's Disease Treated with Rifaximin

Gastroenterology ◽

10.1016/s0016-5085(18)31595-6 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-388-S-389

Author(s):

Scott D. Lee ◽

Anand Singla ◽

Stephen J. Rulyak ◽

Kindra D. Clark-Snustad

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Clinical Response ◽

Crossover Trial ◽

Download Full-text

P142 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL TO EVALUATE INDUCTION OF CLINICAL RESPONSE IN PATIENTS WITH MODERATE-SEVERE CROHN’S DISEASE TREATED WITH RIFAXIMIN

Gastroenterology ◽

10.1053/j.gastro.2017.11.189 ◽

2018 ◽

Vol 154 (1) ◽

pp. S73-S74 ◽

Author(s):

Scott D. Lee ◽

Anand Singla ◽

Stephen J. Rulyak ◽

Kindra D. Clark-Snustad

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Clinical Response ◽

Crossover Trial ◽

Download Full-text

P142 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL TO EVALUATE INDUCTION OF CLINICAL RESPONSE IN PATIENTS WITH MODERATE-SEVERE CROHN’S DISEASE TREATED WITH RIFAXIMIN

Inflammatory Bowel Diseases ◽

10.1093/ibd/izy037.010 ◽

2018 ◽

Vol 24 (suppl_1) ◽

pp. S51-S51

Author(s):

Scott D Lee ◽

Anand Singla ◽

Stephen J Rulyak ◽

Kindra D Clark-Snustad

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Clinical Response ◽

Crossover Trial ◽

Download Full-text

Ornidazole for Prophylaxis of Postoperative Crohn's Disease Recurrence: A Randomized, Double-Blind, Placebo-Controlled Trial

Yearbook of Gastroenterology ◽

10.1016/s0739-5930(08)70327-1 ◽

2006 ◽

Vol 2006 ◽

pp. 117-118

Author(s):

G.R. Lichtenstein

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Controlled Trial ◽

Disease Recurrence ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of P087 - SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn’s disease naive to immunomodulators and biologic therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718140561.793485253 ◽

2013 ◽

Author(s):

Richard Pollok

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Biologic Therapy ◽

Controlled Trial ◽

Download Full-text

Mesalamine(M) in Crohn's disease (CD) patients with prednisolone-induced remission: Effect on steroid weaning and remission maintenance in the year after weaning: A placebo-controlled, multicentre double-blind trial

Gastroenterology ◽

10.1016/0016-5085(95)27817-6 ◽

1995 ◽

Vol 108 (4) ◽

pp. A878 ◽

Author(s):

R. Modigliani ◽

J.F. Colombel ◽

J.L. Dupas ◽

M. Dapoigny ◽

Y. Bouhnik ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Remission Maintenance

Download Full-text